Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

NCT: NCT05714501 · COMPLETED

NCT IDNCT05714501
StatusCOMPLETED
Start Date2023-10-09
Completion2025-05-12
SponsorPerfuze (INDUSTRY)
First posted
Last updated

Brief Summary

The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.

Frequently Asked Questions

What is Millipede AspiRation for Revascularization in Stroke (MARRS) Study?

Millipede AspiRation for Revascularization in Stroke (MARRS) Study is a clinical trial registered under NCT05714501. Current status: COMPLETED.

What is the status of NCT05714501?

The current status of NCT05714501 (Millipede AspiRation for Revascularization in Stroke (MARRS) Study) is: COMPLETED.

When did Millipede AspiRation for Revascularization in Stroke (MARRS) Study start?

Millipede AspiRation for Revascularization in Stroke (MARRS) Study started on 2023-10-09.

Related Devices

K232524Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube SetPerfuze, Ltd. K242504Millipede 088 Access Catheter; Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube SetPerfuze, Ltd. K250012Millipede 070 Aspiration Catheter; Perfuze Aspiration Tube SetPerfuze, Ltd. K214048Millipede 088 Access CatheterPerfuze, Ltd. K231802Millipede 088 Access CatheterPerfuze, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑